Mycronic AbOMXSTO: MYCR

MYCR: Flat sales and strong Global Technologies growth offset order declines; EBIT margin at 17%

· Issued by Mycronic Ab

Order intake declined 19% year-over-year, but sales remained flat as strong growth in Global Technologies offset declines elsewhere. EBIT margin was 17% for the quarter, with continued R&D investment and a positive outlook for Global Technologies and High Volume divisions.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.